John Huffman, MD
Anesthesiology · Arlington, VANPI 1194782243
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $20,810 of the $30,374 with a category attached, or 68.5%. Medtronic accounts for 92.4% of it on its own, with 18 other manufacturers making up the rest. Reporting peaked in 2019 at $16,023 and has fallen 92.2% since, to $1,255 in 2025. Among anesthesiology clinicians in VA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 278 payments — averaging $109.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$28K
- Nevro Corp.$729
- Abbott$357
- MML US, Inc.$260
- Tersera Therapeutics LLC$218
- Boston Scientific$163
- plus $591 from 13 others
Across 26 payments — averaging $8694.42 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$226K
What the payments were for
- Speaking & faculty fees$20,81069%
- Food & beverage$9,56431%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 212 | $28,055 |
| Nevro Corp. | 9 | $729 |
| Abbott | 12 | $357 |
| MML US, Inc. | 5 | $260 |
| Tersera Therapeutics LLC | 10 | $218 |
| Boston Scientific | 5 | $163 |
| Globus Medical | 6 | $159 |
| Saluda Medical Americas, Inc. | 1 | $115 |
| Collegium Pharmaceutical, Inc. | 3 | $58 |
| Biodelivery Sciences International, Inc. | 4 | $52 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $40 |
| Bioventus LLC | 1 | $30 |
| Daiichi Sankyo Inc. | 1 | $29 |
| Nalu Medical, Inc. | 1 | $22 |
| Fidia Pharma USA Inc. | 1 | $22 |
| Vertex | 1 | $18 |
| Kaleo, Inc. | 1 | $17 |
| Scilex Pharmaceuticals Inc. | 1 | $14 |
| Johnson & Johnson | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ADAPTIVESTIM$15,360
- INTELLIS ADAPTIVESTIM$3,471
- SYNCHROMEDII$3,434
- SYNCHROMED$450
- Omnia$345
- MYSTIM$316
- ReActiv8$205
- ASCENDA$176
- PROCLAIM$158
- Senza$155
- INCEPTIV$131
- Evoke$115
How this compares
$30,374 in reported general payments places this provider in the 95th percentile of 1,065 anesthesiology providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OxycontinOxycodone Hcl | 28 | $23,546 |
| NucyntaTapentadol Hcl | 11 | $12,805 |
| BelbucaBuprenorphine Hcl | 12 | $12,470 |
| Fentanyl | 48 | $8,289 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 116 | $3,527 |
| Hydromorphone Hcl | 147 | $3,219 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 49 | $2,886 |
| Oxycodone Hcl | 154 | $2,131 |
| Clonidine | 11 | $2,128 |
| Gabapentin | 120 | $1,605 |
| Pregabalin | 34 | $1,598 |
| Morphine Sulfate ErMorphine Sulfate | 35 | $1,221 |
| Morphine Sulfate | 26 | $1,100 |
| Tramadol Hcl ErTramadol Hcl | 16 | $978 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 20 | $778 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Nucynta, Belbuca | $58 | $25,27523 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,065 anesthesiology providers in Virginia.
Other anesthesiology in Arlington
- Elysha DinhArlington$8K
- Dhiraj JagasiaArlington$2K
- Joseph SmithLeesburg$111K
- Sonia SzlykFairfax$90K
- Jeffrey GreenRichmond$81K
- Tejal RajuChristiansburg$64K
- Bimal GandhiFalls Church$26K
- Neelam BandiFairfax$17K
- Nabil ElkassabanyCharlottesville$14K
- Ramatia MahboobiAlexandria$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.